Status:
UNKNOWN
A Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy
Lead Sponsor:
Renmin Hospital of Wuhan University
Conditions:
Adenoma Detection Rate
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Colonoscopy is a key technique in the detection and diagnosis of lower gastrointestinal diseases. High quality endoscopy results in better disease outcomes. However, the operant level of different end...
Detailed Description
This study aims to construct a real-time quality monitoring system based on computer vision, named Endo.Angel, which is used to monitor the velocity of insertion of the endoscope, record the time of i...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Male or female aged 18 years or above;
- Colonoscopy is needed to further characterize gastrointestinal diseases;
- Ability to read, understand and sign informed consent forms;
- The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures.
- Exclusion criteria:
- Participated in other clinical trials, signed informed consent forms and followed up in other clinical trials.
- Participate in a drug clinical trial and during the elution period of the trial or control drug
- Drug or alcohol abuse or mental disorder in the last 5 years;
- Pregnant or lactating women;
- Patients with multiple polyp syndrome;
- Patients with known space-occupying tumor or intestinal stenosis;
- Patients with known perforation or colonic obstruction;
- A history of anaphylaxis with antispasmodic has been documented;
- The researchers did not consider the subjects suitable for colonoscopy;
- The researchers determined that the subjects had high-risk diseases or other special conditions that were not appropriate for clinical trials.
Exclusion
Key Trial Info
Start Date :
August 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
1076 Patients enrolled
Trial Details
Trial ID
NCT04102631
Start Date
August 30 2019
End Date
December 31 2019
Last Update
September 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renmin Hospital of Wuhan University
Wuhan, Hubei, China, 430060